MeSH tree: C06.405.469.491
After surgery for colon cancer, many patients face the question of whether follow-up chemotherapy is necessary to prevent a possible relapse. The decision is particularly difficult in so-called Stage II, the intermediate-risk ...
15 hours ago
0
3
In a recent study, Stevens researchers have shown how colorectal cancers can evolve from mature intestinal cells that revert to stem cells. These findings explain why colorectal cancers are so resistant to treatment and can ...
Jun 1, 2026
0
5
It's increasingly common to see headlines and social media conversations about the rise in colorectal cancer among younger adults. In fact, the growing incidence of colorectal cancer in people under age 50 helped drive the ...
Jun 1, 2026
0
4
A study led by researchers at Moffitt Cancer Center helps explain why uveal melanoma, the most common form of eye cancer, often spreads to the liver. The uvea is the middle layer of the eye, including the iris.
May 29, 2026
0
3
Researchers at the Faculty of Information Technology at the University of Jyväskylä have used artificial intelligence to speed up the analysis of colorectal cancer samples and predict the functioning of the cells' DNA repair ...
May 28, 2026
0
4
A new analysis of clinical trial data led by Anisha P. Ganguly, MD, MPH, a general internist at UNC Health and member of UNC Lineberger Comprehensive Cancer Center, has proven that mailed fecal immunochemical tests can drastically ...
May 27, 2026
0
2
More than a decade after removal of an adenoma—a precancerous mass—from the colon, alterations to the gut microbiome and metabolites remain and may drive heightened risk of colorectal cancer (CRC), according to a study led ...
May 27, 2026
0
13
With colorectal cancer a growing concern among younger people, the American Cancer Society has endorsed two new types of stool tests to encourage people to get screened, while also recommending a limited role for new blood ...
May 27, 2026
0
8
Enough time had passed since the patient's previous colonoscopy that she met the criteria to undergo another, said Dr. Steven Itzkowitz, a gastroenterologist at the Icahn School of Medicine at Mount Sinai in New York.
May 26, 2026
0
95
Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. According to a new preclinical study by Weill Cornell Medicine and MD Anderson Cancer Center investigators, ...
May 21, 2026
0
6
